Destination Unlimited

AHEAD Study Investigator Meeting

On behalf of Shire, we are delighted to formally invite you to the upcoming AHEAD Study Investigators’ Meeting which will be held in Berlin, just before the ISTH Congress. The objectives of this meeting are to share data of most recent interim analysis, to discuss future analyses, data dissemination and publication plans and to introduce the new study amendment, that allows follow-up and inclusion of patients treated with ADYNOVATE/BAX 855.


Meeting date: Saturday, July 8th 2017, from 1.30 to 4.30pm CEDT

Meeting location: Hilton Berlin, Mohrenstrasse 30, 10117 Berlin, Germany


More information will be provided to you in due course. 


YES, I confirm my participation

NO, I’m unable to attend this Investigator Meeting


Please don’t hesitate to contact us for any questions you might have. 


Alessandro Gringeri, MD, MSc

AHEAD Study Medical Director

Global Medical Affairs - Hematology


Tel: +43 (0) 1 20100 247 6226

Katharina Steinitz-Trost, PhD

AHEAD Study Project Lead

Global Medical Affairs - Hematology


Tel: +43 (0)1 20100 247 6034



Destination Unlimited

{{ popup_title }}

{{ popup_close_text }}